Account
Inquiry
QSC tirzepatide is a high-purity pharmaceutical intermediate developed for research applications. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist demonstrates superior efficacy in glucose control and weight management compared to similar compounds.
The compound appears as white powder with molecular formula C225H348N48O68 and molecular weight of 4813.45. Our qsc tirzepatide is carefully processed to ensure complete removal of trifluoroacetic acid (TFA), making it safer for research purposes.
Key benefits of our qsc tirzepatide include: improved blood sugar control, reduced hyperglycemia, decreased appetite and caloric intake, and potential weight loss effects. These properties make it valuable for metabolic disorder research.
We offer flexible customization options including: mass production capabilities, vial size and content customization, various cap color options, and vacuum-sealed packaging to ensure product stability. Fresh batches are produced every 6-8 days to guarantee quality.
For optimal storage, maintain qsc tirzepatide at -20°C in dry, dark conditions. Lyophilized powder remains stable for extended periods when properly stored. This product is intended for research use only and not for human consumption.
Our manufacturing process ensures high purity (>99%) with rigorous quality control. The product is shipped as non-hazardous chemical under ambient temperature conditions, suitable for research facilities worldwide.
